ES2179932T3 - Nuevos derivados de carbapenem. - Google Patents

Nuevos derivados de carbapenem.

Info

Publication number
ES2179932T3
ES2179932T3 ES96905036T ES96905036T ES2179932T3 ES 2179932 T3 ES2179932 T3 ES 2179932T3 ES 96905036 T ES96905036 T ES 96905036T ES 96905036 T ES96905036 T ES 96905036T ES 2179932 T3 ES2179932 T3 ES 2179932T3
Authority
ES
Spain
Prior art keywords
carbapenem
new derivatives
gram
represented
powerful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96905036T
Other languages
English (en)
Inventor
Kazuhiro Aihara
Yuko Kano
Sohjiro Shiokawa
Toshiro Sasaki
Fumihito Setsu
Yumiko Toyooka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Application granted granted Critical
Publication of ES2179932T3 publication Critical patent/ES2179932T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/40—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by an aliphatic carboxylic acid, which is substituted by hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE DESCRIBEN NUEVOS DERIVADOS DEL CARBAPENEM, REPRESENTADOS POR LA SIGUIENTE FORMULA (I), CON UN GRUPO IMIDAZO[5,1-B]TIAZOLIO-6ILMETIL EN LA POSICION 2. LOS COMPUESTOS REPRESENTADOS POR LA FORMULA (I) TIENEN UNA POTENTE ACTIVIDAD ANTIBACTERIANA CONTRA UN AMPLIO ESPECTRO DE BACTERIAS GRAM-POSITIVAS Y GRAM-NEGATIVAS INCLUYENDO PSEUDOMONAS AERUGINOSA Y, ADEMAS, TIENEN UNA POTENTE ACTIVIDAD ANTIBACTERIANA CONTRA VARIAS BACTERIAS PRODUCTORAS DE {BE}-LACTAMASAS Y MRSA Y SON MUY ESTABLES CONTRA DHP-1.
ES96905036T 1995-03-10 1996-03-08 Nuevos derivados de carbapenem. Expired - Lifetime ES2179932T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5161695 1995-03-10

Publications (1)

Publication Number Publication Date
ES2179932T3 true ES2179932T3 (es) 2003-02-01

Family

ID=12891830

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96905036T Expired - Lifetime ES2179932T3 (es) 1995-03-10 1996-03-08 Nuevos derivados de carbapenem.

Country Status (9)

Country Link
US (1) US5990101A (es)
EP (1) EP0760370B1 (es)
KR (1) KR100231496B1 (es)
CN (1) CN1057091C (es)
CA (1) CA2189995C (es)
DE (1) DE69622801T2 (es)
ES (1) ES2179932T3 (es)
TW (1) TW425396B (es)
WO (1) WO1996028455A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW445265B (en) * 1996-11-25 2001-07-11 Meiji Seika Kaisha Carbapenem derivatives and antimicrobial agents
ID22519A (id) 1997-01-28 1999-10-28 Meiji Seika Kaisha Turunan-turunan karbapenem yang baru
EP1003747A4 (en) * 1997-08-13 2002-11-06 Merck & Co Inc CARBAPENEME ASSOCIATED BY A METHYLENE GROUP WITH A NAPHTHOSULTAM DERIVATIVE
DE69916287T2 (de) 1998-06-17 2005-03-24 Merck & Co., Inc. Verfahren zur synthese von carbapenem-zwischenprodukten
US6458780B1 (en) 1998-07-27 2002-10-01 Meiji Seika Kaisha, Ltd. Carbapenem derivatives
JP2005231997A (ja) * 2000-01-24 2005-09-02 Meiji Seika Kaisha Ltd カルバペネム誘導体の製造法
ES2228896T3 (es) * 2000-01-26 2005-04-16 Meiji Seika Kaisha, Ltd. Nuevos derivados de carbapenem.
US6825187B2 (en) 2000-01-26 2004-11-30 Meiji Seika Kaisha, Ltd. Carbapenem derivatives of quarternary salt type
US7482445B2 (en) 2003-06-18 2009-01-27 Meiji Seika Kaisha, Ltd. Crystalline carbapenem intermediate
TW201920202A (zh) * 2017-08-17 2019-06-01 瑞士商愛杜西亞製藥有限公司 吲哚胺2,3-二氧酶及/或色胺酸2,3-二氧酶的抑制劑

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
JPS6261985A (ja) * 1985-09-11 1987-03-18 Sankyo Co Ltd カルバペネム化合物およびその製法
JPH075607B2 (ja) * 1990-10-12 1995-01-25 日本レダリー株式会社 カルバペネム化合物の製造法
JPH05230573A (ja) * 1992-02-25 1993-09-07 Furukawa Alum Co Ltd 耐食性および強度に優れたアルミニウム合金製ブレージングシート
JPH06211908A (ja) * 1992-11-30 1994-08-02 Shin Etsu Chem Co Ltd 塩化ビニル系重合体の製造方法
WO1995007912A1 (en) * 1993-09-16 1995-03-23 Meiji Seika Kabushiki Kaisha Novel cephem derivative

Also Published As

Publication number Publication date
WO1996028455A1 (en) 1996-09-19
TW425396B (en) 2001-03-11
DE69622801T2 (de) 2003-03-27
US5990101A (en) 1999-11-23
CN1148390A (zh) 1997-04-23
EP0760370B1 (en) 2002-08-07
CA2189995C (en) 2001-01-23
EP0760370A1 (en) 1997-03-05
DE69622801D1 (de) 2002-09-12
EP0760370A4 (en) 1997-05-28
CA2189995A1 (en) 1996-09-19
KR100231496B1 (ko) 1999-11-15
CN1057091C (zh) 2000-10-04
KR970702865A (ko) 1997-06-10

Similar Documents

Publication Publication Date Title
AU5377698A (en) Substituted pyrrolyl compounds for the treatment of inflammation
ES2179932T3 (es) Nuevos derivados de carbapenem.
BR0210016A (pt) Heterociclos bicìclicos contendo nitrogênio, para uso como antibacterianos
KR0145958B1 (en) Antibacterial agents
CA2153775A1 (en) Potentiation of Temozolomide in Human Tumour Cells
EA200400489A1 (ru) Препараты, содержащие цефалоспориновое соединение, и их применение в лечении бактериальных инфекций у кошек и собак
CA2041871A1 (en) Contact lens cleaning and disinfecting with combinations of polymeric quaternary ammonium compounds and enzymes
AU5299096A (en) Use of amidoamines in ophthalmic compositions
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
EP1560821B8 (en) Antibacterial agents
CA2184886A1 (en) Method of strengthening antibacterial action of antibiotics
AR005642A1 (es) Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios
CA2309172A1 (en) Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
AU1377995A (en) A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
ECSP056233A (es) Nuevos derivados de lincomicina que poseen actividad antimicrobiana
CA2267309A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
ATE166787T1 (de) Ein gegen staphylococcus-ganoderme-lucidum- extrakt enthaltendes antimikrobielles mittel
AU6332799A (en) Hydroxystilbene compounds used as microbicidal active substances
GT199800162A (es) Derivados de eritromicina triciclicos.
IL57853A0 (en) Pseudotrisaccharides,their production and their use as medicaments
DE3886718D1 (de) Hydrogenierte Derivate von Antibiotika A/16686.
WO2003078367A3 (en) Benzyl alcohol derivatives and their use as antimicrobial agents
DK1618106T3 (da) Carbacephem beta-lactam antibiotika
SE7609181L (sv) Polyaminforeningar
DK170189D0 (da) Aglykoner af a/16686-antibiotika